Signal Peptide Database - Drosophila melanogaster

 Entry Details
ID   29727
Source Database   UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number   P16621    (Created: 1990-08-01 Updated: 2009-01-20)
UniProtKB/Swiss-Prot Entry Name   LAR_DROME
Protein Name   Tyrosine-protein phosphatase Lar
Gene   Lar
Organism Scientific   Drosophila melanogaster
Organism Common   Fruit fly
Lineage   Eukaryota
  Metazoa
    Arthropoda
      Hexapoda
        Insecta
          Pterygota
            Neoptera
              Endopterygota
                Diptera
                  Brachycera
                    Muscomorpha
                      Ephydroidea
                        Drosophilidae
                          Drosophila
                            Sophophora
Protein Length [aa]   2029
Protein Mass [Da]   229056
Features  
TypeDescriptionStatusStartEnd
signal peptide         1   32
chain   Tyrosine-protein phosphatase Lar      33   2029
disulfide bond      potential   57   111
disulfide bond      potential   161   209
disulfide bond      potential   256   301
transmembrane region      potential   1378   1402
topological domain   Extracellular   potential   33   1377
topological domain   Cytoplasmic   potential   1403   2029
domain   Ig-like C2-type 1      36   128
domain   Ig-like C2-type 2      140   224
domain   Ig-like C2-type 3      234   316
domain   Fibronectin type-III 1      322   410
domain   Fibronectin type-III 2      416   508
domain   Fibronectin type-III 3      515   603
domain   Fibronectin type-III 4      610   704
domain   Fibronectin type-III 5      709   807
domain   Fibronectin type-III 6      812   904
domain   Fibronectin type-III 7      909   1002
domain   Fibronectin type-III 8      1006   1099
domain   Fibronectin type-III 9      1101   1203
domain   Tyrosine-protein phosphatase 1      1474   1729
domain   Tyrosine-protein phosphatase 2      1761   2020
modified residue   Phosphothreonine      1572   1572
glycosylation site   N-linked (GlcNAc...)   potential   176   176
glycosylation site   N-linked (GlcNAc...)   potential   253   253
glycosylation site   N-linked (GlcNAc...)   potential   298   298
glycosylation site   N-linked (GlcNAc...)   potential   553   553
glycosylation site   N-linked (GlcNAc...)   potential   616   616
glycosylation site   N-linked (GlcNAc...)   potential   666   666
glycosylation site   N-linked (GlcNAc...)   potential   721   721
glycosylation site   N-linked (GlcNAc...)   potential   774   774
glycosylation site   N-linked (GlcNAc...)   potential   915   915
glycosylation site   N-linked (GlcNAc...)   potential   962   962
glycosylation site   N-linked (GlcNAc...)   potential   1183   1183
glycosylation site   N-linked (GlcNAc...)   potential   1304   1304
active site   Phosphocysteine intermediate   by similarity   1670   1670
active site   Phosphocysteine intermediate   by similarity   1961   1961
SP Length   32
 ----+----1----+----2----+----3----+----4----+----5
Signal Peptide MGLQMTAARPIAALSLLVLSLLTWTHPTIVDA
Sequence MGLQMTAARPIAALSLLVLSLLTWTHPTIVDAAHPPEIIRKPQNQGVRVG
GVASFYCAARGDPPPSIVWRKNGKKVSGTQSRYTVLEQPGGISILRIEPV
RAGRDDAPYECVAENGVGDAVSADATLT
IYEGDKTPAGFPVITQGPGTRV
IEVGHTVLMTCKAIGNPTPNIYWIK
NQTKVDMSNPRYSLKDGFLQIENSR
EEDQGKYECVAENSMGTEHSKATN
LYVKVRRVPPTFSRPPETISEVMLGS
NL
NLSCIAVGSPMPHVKWMKGSEDLTPENEMPIGRNVLQLINIQESANYT
CIAASTLGQIDSVSVV
KVQSLPTAPTDVQISEVTATSVRLEWSYKGPEDL
QYYVIQYKPKNANQAFSEISGIITMYYVVRALSPYTEYEFYVIAVNNIGR
GPPSAPATCT
TGETKMESAPRNVQVRTLSSSTMVITWEPPETPNGQVTGY
KVYYTTNSNQPEASWNSQMVDNSELTTVSELTPHAIYTVRVQAYTSMGAG
PMSTPVQV
KAQQGVPSQPSNFRATDIGETAVTLQWTKPTHSSENIVHYEL
YW
NDTYANQAHHKRISNSEAYTLDGLYPDTLYYIWLAARSQRGEGATTPP
IPV
RTKQYVPGAPPRNITAIATSSTTISLSWLPPPVERSNGRIIYYKVFF
VEVGREDDEATTMTL
NMTSIVLDELKRWTEYKIWVLAGTSVGDGPRSHPI
ILRT
QEDVPGDPQDVKATPLNSTSIHVSWKPPLEKDRNGIIRGYHIHAQE
LRDEGKGFLNEPFKFDVVDTLEF
NVTGLQPDTKYSIQVAALTRKGDGDRS
AAIVVKT
PGGVPVRPTVSLKIMEREPIVSIELEWERPAQTYGELRGYRLR
WGVKDQALKEEMLSGPQMTKKRFDNLERGVEYEFRVAGSNHIGIGQETVK
IFQT
PEGTPGGPPSNITIRFQTPDVLCVTWDPPTREHRNGIITRYDVQFH
KKIDHGLGSER
NMTLRKAVFTNLEENTEYIFRVRAYTKQGAGPFSDKLIV
ET
ERDMGRAPMSLQAEATSEQTAEIWWEPVTSRGKLLGYKIFYTMTAVED
LDDWQTKTVGLTESADLVNLEKFAQYAVAIAARFKNGLGRLSEKVTVRI
K
PEDVPLNLRAHDVSTHSMTLSWSPPIRLTPVNYKISFDAMKVFVDSQGFS
QTQIVPKREIILKHYVKTHTINELSPFTTYNV
NVSAIPSDYSYRPPTKIT
VTT
QMAAPQPMVKPDFYGVVNGEEILVILPQASEEYGPISHYYLVVVPED
KSNLHKIPDQFLTDDLLPGRNKPERPNAPYIAAKFPQRSIPFTFHLGSGD
DYH
NFTNRKLEREKRYRIFVRAVVDTPQKHLYTSSPFSEFLSLDMREAPP
GERPHRPDPNWPAEPEVSVNRNKDEPE
ILWVVLPLMVSTFIVSTALIVLC
VV
KRRRQPCKTPDQAAVTRPLMAADLGAGPTPSDPVDMRRLNFQTPGMIS
HPPIPISEFANHIERLKSNDNQK
FSQEYESIEPGQQFTWDNSNLEHNKSK
NRYANVTAYDHSRVQLPAVEGVVGSDYINANYCDGYRKHNAYVATQGPLQ
ETFVDFWRMCWELKTATIVMM
TRLEERTRIKCDQYWPTRGTETYGQIFVT
ITETQELATYSIRTFQLCRQGFNDRREIKQLQFTAWPDHGVPDHPAPFLQ
FLRRCRALTPPESGPVIVH
CSAGVGRTGCYIVIDSMLERMKHEKIIDIYG
HVTCLRAQRNYMVQTEDQYIFIHDAILEA
IICGVTEVPARNLHTHLQKLL
ITEPGETISG
MEVEFKKLSNVKMDSSKFVTANLPCNKHKNRLVHILPYES
SRVYLTPIHGIEGSDYVNASFIDGYRYRSAYIAAQGPVQDAAEDFWRMLW
EHNSTIVVMLTKLKEMGREKCFQYWPHERSVRYQYYVVDPIAEYNMPQYK
LREFKVTDARDGSSRTVRQFQFIDWPEQGVPKSGEGFIDFIGQVHKTKEQ
FGQDGPITVH
CSAGVGRSGVFITLSIVLERMQYEGVLDVFQTVRILRSQR
PAMVQTEDQYHFCYRAALEY
LGSFDNYTN
Original MGLQMTAARPIAALSLLVLSLLTWTHPTIVDAAHPPEIIRKPQNQGVRVG
GVASFYCAARGDPPPSIVWRKNGKKVSGTQSRYTVLEQPGGISILRIEPV
RAGRDDAPYECVAENGVGDAVSADATLTIYEGDKTPAGFPVITQGPGTRV
IEVGHTVLMTCKAIGNPTPNIYWIKNQTKVDMSNPRYSLKDGFLQIENSR
EEDQGKYECVAENSMGTEHSKATNLYVKVRRVPPTFSRPPETISEVMLGS
NLNLSCIAVGSPMPHVKWMKGSEDLTPENEMPIGRNVLQLINIQESANYT
CIAASTLGQIDSVSVVKVQSLPTAPTDVQISEVTATSVRLEWSYKGPEDL
QYYVIQYKPKNANQAFSEISGIITMYYVVRALSPYTEYEFYVIAVNNIGR
GPPSAPATCTTGETKMESAPRNVQVRTLSSSTMVITWEPPETPNGQVTGY
KVYYTTNSNQPEASWNSQMVDNSELTTVSELTPHAIYTVRVQAYTSMGAG
PMSTPVQVKAQQGVPSQPSNFRATDIGETAVTLQWTKPTHSSENIVHYEL
YWNDTYANQAHHKRISNSEAYTLDGLYPDTLYYIWLAARSQRGEGATTPP
IPVRTKQYVPGAPPRNITAIATSSTTISLSWLPPPVERSNGRIIYYKVFF
VEVGREDDEATTMTLNMTSIVLDELKRWTEYKIWVLAGTSVGDGPRSHPI
ILRTQEDVPGDPQDVKATPLNSTSIHVSWKPPLEKDRNGIIRGYHIHAQE
LRDEGKGFLNEPFKFDVVDTLEFNVTGLQPDTKYSIQVAALTRKGDGDRS
AAIVVKTPGGVPVRPTVSLKIMEREPIVSIELEWERPAQTYGELRGYRLR
WGVKDQALKEEMLSGPQMTKKRFDNLERGVEYEFRVAGSNHIGIGQETVK
IFQTPEGTPGGPPSNITIRFQTPDVLCVTWDPPTREHRNGIITRYDVQFH
KKIDHGLGSERNMTLRKAVFTNLEENTEYIFRVRAYTKQGAGPFSDKLIV
ETERDMGRAPMSLQAEATSEQTAEIWWEPVTSRGKLLGYKIFYTMTAVED
LDDWQTKTVGLTESADLVNLEKFAQYAVAIAARFKNGLGRLSEKVTVRIK
PEDVPLNLRAHDVSTHSMTLSWSPPIRLTPVNYKISFDAMKVFVDSQGFS
QTQIVPKREIILKHYVKTHTINELSPFTTYNVNVSAIPSDYSYRPPTKIT
VTTQMAAPQPMVKPDFYGVVNGEEILVILPQASEEYGPISHYYLVVVPED
KSNLHKIPDQFLTDDLLPGRNKPERPNAPYIAAKFPQRSIPFTFHLGSGD
DYHNFTNRKLEREKRYRIFVRAVVDTPQKHLYTSSPFSEFLSLDMREAPP
GERPHRPDPNWPAEPEVSVNRNKDEPEILWVVLPLMVSTFIVSTALIVLC
VVKRRRQPCKTPDQAAVTRPLMAADLGAGPTPSDPVDMRRLNFQTPGMIS
HPPIPISEFANHIERLKSNDNQKFSQEYESIEPGQQFTWDNSNLEHNKSK
NRYANVTAYDHSRVQLPAVEGVVGSDYINANYCDGYRKHNAYVATQGPLQ
ETFVDFWRMCWELKTATIVMMTRLEERTRIKCDQYWPTRGTETYGQIFVT
ITETQELATYSIRTFQLCRQGFNDRREIKQLQFTAWPDHGVPDHPAPFLQ
FLRRCRALTPPESGPVIVHCSAGVGRTGCYIVIDSMLERMKHEKIIDIYG
HVTCLRAQRNYMVQTEDQYIFIHDAILEAIICGVTEVPARNLHTHLQKLL
ITEPGETISGMEVEFKKLSNVKMDSSKFVTANLPCNKHKNRLVHILPYES
SRVYLTPIHGIEGSDYVNASFIDGYRYRSAYIAAQGPVQDAAEDFWRMLW
EHNSTIVVMLTKLKEMGREKCFQYWPHERSVRYQYYVVDPIAEYNMPQYK
LREFKVTDARDGSSRTVRQFQFIDWPEQGVPKSGEGFIDFIGQVHKTKEQ
FGQDGPITVHCSAGVGRSGVFITLSIVLERMQYEGVLDVFQTVRILRSQR
PAMVQTEDQYHFCYRAALEYLGSFDNYTN
 ----+----1----+----2----+----3----+----4----+----5
Hydropathies  
 

© 2007-2017 Dr. Katja Kapp, Kassel & thpr.net e. K., Dresden, Germany, last update 2010-06-11